Brian J. Brille
See Remarks at Caris Life Sciences Inc.
Sits on 1 board. Last updated September 27, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 1 year
- Director since
- 2025
1 year of board service in total across 1 board, counting each seat separately. Longest: Caris Life Sciences Inc., 1 year.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Caris Life Sciences Inc. June 4, 202682.6%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 17, 2026 | Caris Life Sciences Inc. | Option exercise | +400,000 | $2.44 | $976,000 |
| Sep 17, 2026 | Caris Life Sciences Inc. | Open-market sale | −400,000 | $30.33 | $12,132,080 |
| May 15, 2026 | Caris Life Sciences Inc. | Shares withheld for tax | −13,987 | $15.25 | $213,302 |
| Mar 6, 2026 | Caris Life Sciences Inc. | Grant or award | +83,162 | — | — |
| Dec 11, 2025 | Caris Life Sciences Inc. | Gift | −650 | — | — |
| Dec 10, 2025 | Caris Life Sciences Inc. | Gift | −650 | — | — |
| Jun 20, 2025 | Caris Life Sciences Inc. | Open-market purchase | +30,000 | $21.00 | $630,000 |
| Jun 18, 2025 | Caris Life Sciences Inc. | Grant or award | +132,428 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.